At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03696 INSILICO
Closed 05-21 16:08:15
45.840
-2.320
-4.82%
High49.300Low45.360Vol3.58M
Open49.300D1 Closing48.160Amplitude8.18%
Mkt Cap26.20BTradable Cap26.20BTotal Shares571.62M
T/O168.19MT/O Rate0.63%Tradable Shares571.62M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Movement Alert｜Insilico Medicine Declines 5.19% in Regular Trading, Trading at 45.88 HKD
Market Focus  ·  15:21
Movement Alert｜Insilico Medicine Declines 5.19% in Regular Trading, Trading at 45.88 HKD
Movement Alert｜Insilico Medicine Declines 5.19% in Regular Trading, Trading at 48.94 HKD
Market Focus  ·  05-20 13:55
Movement Alert｜Insilico Medicine Declines 5.19% in Regular Trading, Trading at 48.94 HKD
A Look At InSilico Medicine (SEHK:3696) Valuation After Recent Share Price Pullback
Simply Wall St.  ·  05-18 20:25
A Look At InSilico Medicine (SEHK:3696) Valuation After Recent Share Price Pullback
InSilico Ribo Oligonucleotide Alliance Tests AI Drug Discovery Model
Simply Wall St.  ·  05-17
InSilico Ribo Oligonucleotide Alliance Tests AI Drug Discovery Model
BRIEF-Insilico Medicine And Ribo Enter Strategic Collaboration Agreement
Reuters  ·  05-12
BRIEF-Insilico Medicine And Ribo Enter Strategic Collaboration Agreement
Insilico Medicine partners with Ribo Life Science on AI-driven oligonucleotide R&D
Reuters  ·  05-12
Insilico Medicine partners with Ribo Life Science on AI-driven oligonucleotide R&D
Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of Rna Interference and Oligonucleotide Therapeutics Development
THOMSON REUTERS  ·  05-12
Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of Rna Interference and Oligonucleotide Therapeutics Development
Stock Track | INSILICO Soars 5.05% Intraday on Google Cloud Collaboration for AI Drug Discovery
Stock Track  ·  05-11
Stock Track | INSILICO Soars 5.05% Intraday on Google Cloud Collaboration for AI Drug Discovery
INSILICO Shares Rise Nearly 4% in Hong Kong Session Following Google Cloud Collaboration Announcement
Stock News  ·  05-11
INSILICO Shares Rise Nearly 4% in Hong Kong Session Following Google Cloud Collaboration Announcement
INSILICO Keeps Share Base Steady in April 2026, Confirms Public Float Threshold Met
Bulletin Express  ·  05-07
INSILICO Keeps Share Base Steady in April 2026, Confirms Public Float Threshold Met
INSILICO Stock Surges Over 5% in Hong Kong Trading Following Launch of Next-Generation LabClaw System
Stock News  ·  05-07
INSILICO Stock Surges Over 5% in Hong Kong Trading Following Launch of Next-Generation LabClaw System
Stock Track | INSILICO Soars 5.06% Intraday on Nomination of 30th AI-Driven Preclinical Drug Candidate
Stock Track  ·  05-07
Stock Track | INSILICO Soars 5.06% Intraday on Nomination of 30th AI-Driven Preclinical Drug Candidate
InSilico Medicine Invests $105 Million in Wealth Management Products
MT Newswires Live  ·  04-30
InSilico Medicine Invests $105 Million in Wealth Management Products
BRIEF-Insilico Medicine Cayman Topco, Unit Subscribe For Wealth Management Products
Reuters  ·  04-30
BRIEF-Insilico Medicine Cayman Topco, Unit Subscribe For Wealth Management Products
INSILICO Announces Subscription of Financial Products
Stock News  ·  04-30
INSILICO Announces Subscription of Financial Products
Insilico Medicine places USD105.00 million in treasury products, cash position rises to USD596.00 million
Bulletin Express  ·  04-30
Insilico Medicine places USD105.00 million in treasury products, cash position rises to USD596.00 million
Insilico Medicine Cayman Topco - Co and Unit Subscribes for Wealth Management Products on April 29, 2026
THOMSON REUTERS  ·  04-30
Insilico Medicine Cayman Topco - Co and Unit Subscribes for Wealth Management Products on April 29, 2026
Insilico Medicine Cayman Topco - Subscribes to Cmb International USD Money Market Fund for USD50 Mln
THOMSON REUTERS  ·  04-30
Insilico Medicine Cayman Topco - Subscribes to Cmb International USD Money Market Fund for USD50 Mln
Stock Track | Insilico Medicine Soars 5.14% Intraday on China IND Approval for Rentosertib IPF Therapy
Stock Track  ·  04-29
Stock Track | Insilico Medicine Soars 5.14% Intraday on China IND Approval for Rentosertib IPF Therapy
BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled Rentosertib
Reuters  ·  04-29
BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled Rentosertib

Introduction

Company Name.
INSILICO
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
InSilico Medicine Cayman TopCo is a company principally engaged in the research and development of artificial intelligence in pharmaceuticals. The Company is engaged in the research and development of drug discovery engines. In addition, the Company is engaged in the copabdrug discovery and development of disease target identification, generation of novel molecules data, and predicting clinical trial outcomes.
Issue price:
--